Table of Contents
SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
THE SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED) FEBRUARY 18, 2004
NORTHWEST BIOTHERAPEUTICS, INC.
DELAWARE | 0-33393 | 94-3306718 | ||
(STATE OR OTHER JURISDICTION OF INCORPORATION) | (COMMISSION FILE NUMBER) | (I.R.S. EMPLOYER IDENTIFICATION NO.) |
22322 20th Drive SE, Suite 150, Bothell, WA 98021
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES) (ZIP CODE)
(425) 608-3000
REGISTRANT’S TELEPHONE NUMBER, INCLUDING AREA CODE
(FORMER NAME OR FORMER ADDRESS IF CHANGED SINCE LAST REPORT)
ITEM 5. OTHER EVENTS AND REGULATION FD DISCLOSURE. | ||||||||
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS | ||||||||
SIGNATURE | ||||||||
EXHIBIT INDEX | ||||||||
Exhibit 99.1 |
Table of Contents
ITEM 5.OTHER EVENTS AND REGULATION FD DISCLOSURE.
On February 18, 2004, the Registrant announced the resignation of Daniel O. Wilds as Chairman and Chief Executive Officer and as a member of the Registrant’s board of directors. In the course of his resignation, Mr. Wilds did not provide the Registrant with any materials which would have required disclosure pursuant to Item 6 of Form 8-K. A copy of Registrant’s press release dated February 18, 2004 is appended to this Current Report on Form 8-K as Exhibit 99.1, and is being furnished pursuant to Regulation FD.
ITEM 7.FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS
(c) EXHIBITS
99.1 Press Release dated February 18, 2004.
Table of Contents
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
NORTHWEST BIOTHERAPEUTICS, INC. | ||||
By: | /s/ Alton L. Boynton Alton L. Boynton, President | |||
Dated: February 19, 2004 |
Table of Contents
EXHIBIT INDEX
EXHIBIT | ||
NUMBER | DESCRIPTION | |
99.1 | Press Release dated February 18, 2004. |